0 Items
Select Page

Toscana Virus

Toscana virus (TOSV) or Sandfly fever Naples phlebovirus (SFNV) is a member of the genus Phlebovirus of the family Bunyaviridae. TOSV is an arthropod-borne virus that is transmitted by sandfly of the Phlebotomus species, including Phlebotomus perniciosus and Phlebotomus perfiliewi. The virus is a significant cause of aseptic meningitis in endemic areas and the disease caused by TOSV is prevalent during the summer months when the sandfly is most abundant. Although initially isolated in Italy, Toscana virus is now geographical widespread throughout the Mediterranean region including Italy, France, Spain, Portugal, Greece, Croatia, Cyprus and Turkey.

Toscana Virus Background

Toscana virus (TOSV) or Sandfly fever Naples phlebovirus (SFNV) is a member of the genus Phlebovirus of the family Bunyaviridae. TOSV is an enveloped, single-stranded, negative-sense RNA virus. The viral genome is segmented, having three segments that are referred to as large (L), medium (M) and small (S). These segments encode the viral RNA-dependent RNA polymerase, envelope glycoproteins, nucleoproteins and non-structural proteins. Two genotypes of TOSV have been identified, which are referred to as lineage A and lineage B. However, some reports suggest that there may be additional lineages of the virus in circulation (Cusi, MG).

TOSV is an arthropod-borne virus that is transmitted by sandfly of the Phlebotomus species, including Phlebotomus perniciosus and Phlebotomus perfiliewi. Since the virus was first isolated from sandfly in 1971, no bird or small mammal reservoir has been reliably identified, suggesting that infected sandfly may act as vector and reservoir for TOSV. The disease caused by TOSV is prevalent during the summer months when the sandfly is most abundant (Charrel, RN). Although initially isolated in Italy, Toscana virus is now geographical widespread throughout the Mediterranean region including Italy, France, Spain, Portugal, Greece, Croatia, Cyprus and Turkey.

TOSV is a serotype of Sandfly-fever viruses, with a neuroinvasive nature. The virus causes a febrile illness called pappataci-fever (or Sandfly-fever) but can also cause neurological disease including aseptic meningitis, encephalitis or meningoencephalitis. In many cases, TOSV infection is asymptomatic or presents as a self-limiting febrile illness. However, some patients develop a range of neurological symptoms which include meningitis like symptoms, headache, neck-stiffness, nausea, vomiting, myalgia and weakness. Other neurological symptoms have been reported including deafness, speech disorders and paresis.

In Europe, TOSV represents an important emerging pathogen that has the potential to spread to countries outside the Mediterranean. The virus is a significant cause of aseptic meningitis in endemic areas. Currently, there is no antiviral therapy for the treatment of symptomatic cases of TOSV, and no licensed prophylactic vaccine to prevent TOSV infection. Diagnosis of TOSV in humans is achieved using molecular methods to detect the virus or serological methods to measure Toscana virus specific IgM levels in infected patients.

 

References

Cusi MG, Savellini GG, Zanelli G.2010.Toscana virus epidemiology: from Italy to beyond. Open Virol J. 2010 Apr 22;4:22-8.

Charrel RN, Bichaud L, de Lamballerie X.2012.Emergence of Toscana virus in the Mediterranean area. World J Virol. 2012 Oct 12;1(5):135-41.

Toscana Virus Antigens

The Native Antigen Company have developed recombinant Toscana proteins in our mammalian cell expression system. These antigens are suitable for use in assay development, vaccine research and as antigens for the preparation of antibodies.

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Diagnosing HIV in resource-limited settings

In this blog, we discuss the need for improved point-of-care (PoC) diagnostics for HIV and present the virus's cellular mechanism to illustrate our new range of HIV antigens and antibodies. HIV in the developed world On June 5th 1981 in Los Angeles, California, 5...

Our Product Pipeline

If you’ve been following us on social media recently, you might have noticed that we’ve been releasing a lot of new antigens and antibodies. In this blog, we explain how we use the WHO R&D Blueprint to guide our product development and present some highlights from...

From Outbreak to Epidemic: A Short History of The Ebola Virus

In the first of a two-part series, we discuss the history of the Ebola virus up to the ongoing outbreak in the Democratic Republic of Congo, and why this disease has been so challenging to fight. The 2014/15 epidemic In the summer of 2014, the world watched as the...

ELISA Formats for Infectious Disease Diagnostics

The field of diagnostics is rapidly developing, yet ELISA and PCR methods remain the most commonly used techniques in the diagnosis of bacterial and viral infections. In this blog, we discuss the advantages of using serological methods over molecular, PCR-based...

The world’s most extensive range of NS1-specific antibodies for flavivirus research

The Native Antigen Company first gained prominence in 2016, when it developed highly pure Zika virus NS1 protein during the 2015/2016 epidemic. Since then, the company has developed an extensive range of highly specific antigens, antibodies and immunoassays for...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

14 + 2 =

Live Customer Feedback

Join our mailing list

* indicates required